0001179110-21-001510.txt : 20210210
0001179110-21-001510.hdr.sgml : 20210210
20210210162429
ACCESSION NUMBER: 0001179110-21-001510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Utter Christine Marie
CENTRAL INDEX KEY: 0001707685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 21614194
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
edgar.xml
FORM 4 -
X0306
4
2021-02-08
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707685
Utter Christine Marie
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
SVP, Finance & CAO
Common Stock
2021-02-08
4
M
0
2657
33.02
A
19166
D
Common Stock
2021-02-08
4
S
0
2657
66.00
D
16509
D
Stock Option (Right to Buy)
33.02
2021-02-08
4
M
0
2657
33.02
D
2029-01-21
Common Stock
2657
21250
D
Stock Option (Right To Buy)
490.8
2021-04-27
Common Stock
74.0
74
D
Stock Option (Right To Buy)
218.4
2022-01-10
Common Stock
21.0
21
D
Stock Option (Right To Buy)
40.45
2024-09-23
Common Stock
4688.0
4688
D
Stock Option (Right To Buy)
51.0
2025-01-02
Common Stock
17800.0
17800
D
Stock Option (Right to Buy)
18.01
2028-01-02
Common Stock
10000
10000
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
10100.0
10100
D
Stock Option (Right To Buy)
51.16
2030-01-28
Common Stock
23800.0
23800
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
50750
50750
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
Currently exercisable.
This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
Represents an option award of 33,250 options and an option award of 17,500 options. These option awards were each granted on January 6, 2021, and each vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
/s/ Avraham S. Adler, attorney-in-fact
2021-02-10